Dermatologic Management of Hidradenitis Suppurativa and Impact on Pregnancy and Breastfeeding

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that most commonly affects women of childbearing age. The symptoms of the disease are managed with a multitude of topical and systemic medications. The course of HS changes during pregnancy, and some women can experience postpartum flares. Thus, it is important to be aware of how pregnancy may alter the treatment plan for women and impact their choice to breastfeed. The following review summarizes medical management for HS and its safety during pregnancy and breastfeeding. Do

Cite

CITATION STYLE

APA

Chellappan, B., Quoc Nguyen, D. D., Hoyer, P., & Ross, L. (2022). Dermatologic Management of Hidradenitis Suppurativa and Impact on Pregnancy and Breastfeeding. Cutis, 109(3), 160–162. https://doi.org/10.12788/cutis.0480

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free